Captor Therapeutics SA
WSE:CTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Captor Therapeutics SA
WSE:CTX
|
PL |
|
California Resources Corp
F:1CLD
|
US |
Intrinsic Value
The intrinsic value of Captor Therapeutics SA (CTX) under the Base Case is 11.98 PLN per share. Compared with the current market price of 53.7 PLN, the stock appears Overvalued by 78% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Captor Therapeutics Does
Captor Therapeutics is a drug-discovery company that designs medicines based on targeted protein degradation. Instead of trying only to block a disease-causing protein, its approach aims to tag that protein for removal inside the cell. The company mainly works on early-stage research programs for hard-to-treat diseases, especially in oncology and other areas where new treatment options are needed.
- Headquarters
- Poland PL
- Employees
- 98
- IPO date
- Apr 19, 2021
Earnings Waterfall
Captor Therapeutics SA
The intrinsic value for Captor Therapeutics SA (CTX) under the Base Case is 11.98 PLN.
Compared with the current market price of 53.7 PLN, the stock appears Overvalued by 78% .